_what-is-flt3-positive-aml-what-is-gilteritinib-aml-preview-1.jpg "What is FLT3-positive AML? What is gilteritinib? #AML from flt3 itd mutation positive Video Screenshot Preview 1")
Gallery_what-is-flt3-positive-aml-what-is-gilteritinib-aml-preview-3.jpg "What is FLT3-positive AML? What is gilteritinib? #AML from flt3 itd mutation positive Video Screenshot Preview 3")
Gallery_what-is-flt3-positive-aml-what-is-gilteritinib-aml-preview-hqdefault.jpg "What is FLT3-positive AML? What is gilteritinib? #AML from flt3 itd mutation positive Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 2 minutes 43 seconds
👁 View: 726 times
Play Audio:👁 View: 726 times
Description:
HealthTree University for Blood Cancers
HealthTree University for Blood Cancers
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_quizartinib-improves-survival-in-patients-with-flt3-itd-mutated-r-r-aml-quantum-r-trial.webp "Presented by Mark J. Levis, MD, PhD nnDr. Levis presents results of the QuANTUM-R trial, the first positive phase 3 trial to demonstrate improved OS with single-agent quizartinib in the R/R FLT3-ITD AML setting compared with salvage chemotherapy. The data confirm the safety and efficacy of quizartinib and the value of targeting the FLT3-ITD driver mutation with a highly potent and selective FLT3 inhibitor.")
⏲ 4 min 52 sec ✓ 23-Jul-2018
_best-treatment-strategy-for-flt3-itd-aml.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_quizartinib-for-flt3-itd-positive-aml-after-second-line-chemo-or-stem-cell-transplant.webp "Research suggests that a new targeted therapy, quizartinib, may be a safe and effective option to treat a subset of patients with treatment-resistant acute myeloid leukaemia (AML), whose leukaemia has the FLT3-ITD mutation.nnQuizartinib is the first and only single-agent drug that has produced a clinical benefit in AML patients with this deadly mutation who have failed previous therapy.nnThe number of patients bridged to a stem cell transplant was very significant. Dr Levis and his colleagues pl")
⏲ 3 min 26 sec ✓ 16-Jan-2018
_significance-of-flt3-mutations-in-aml.webp "OncLiveTV")
_aml17-trial-update-flt3-itd-mutation-and-daunorubicin-dosage.webp "VJHemOnc – Video Journal of Hematology u0026 HemOnc")
_quizartinib-improves-survival-in-patients-with-flt3-itd-mutated-r-r-aml-quantum-r-trial.jpg)
_best-treatment-strategy-for-flt3-itd-aml.jpg)
_quizartinib-for-flt3-itd-positive-aml-after-second-line-chemo-or-stem-cell-transplant.jpg)
_significance-of-flt3-mutations-in-aml.jpg)
_aml17-trial-update-flt3-itd-mutation-and-daunorubicin-dosage.jpg)
![[+]](/images/menu.gif){kind=small}